Search research articles
Contact Us
Filters
Showing results (181-190 of 329) with videos related to
Page
of 33
Sort By:
Leukemia Research
|
October 1, 1992
Role of interleukin 6 in the growth of myeloma-derived cell lines
B A Barut, L I Zon, M K Cochran, et al.
Cytotherapy
|
July 26, 2003
Predictors of high yield and purify of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma
I J Webb, R L Scholssman, M Jiroutek, et al.
Annals of Internal Medicine
|
July 15, 1992
Leukocyte reduction in blood component therapy
T A Lane, K C Anderson, L T Goodnough, et al.
Bone Marrow Transplantation
|
March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion
E Orsini, E P Alyea, R Schlossman, et al.
Blood
|
March 1, 1986
Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation
T Hercend, T Takvorian, A Nowill, et al.
Blood
|
March 1, 1985
Immunologic heterogeneity of diffuse large cell lymphoma
A S Freedman, A W Boyd, K C Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 5, 2000
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma
E Orsini, E P Alyea, A Chillemi, et al.
Transfusion Science
|
June 7, 1993
Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive
P T Pisciotto, K C Anderson, L T Goodnough, et al.
Blood
|
January 1, 1990
Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium
D C Roy, R Tantravahi, C Murray, et al.
Clinical and Experimental Immunology
|
July 28, 2005
Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients
B Maecker, M S von Bergwelt-Baildon, K S Anderson, et al.
Page
of 33
Search research articles
Search
Showing results (181-190 of 329) with videos related to
Sort By:
Page
of 33
Leukemia Research
|
October 1, 1992
Role of interleukin 6 in the growth of myeloma-derived cell lines
B A Barut, L I Zon, M K Cochran, et al.
Cytotherapy
|
July 26, 2003
Predictors of high yield and purify of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma
I J Webb, R L Scholssman, M Jiroutek, et al.
Annals of Internal Medicine
|
July 15, 1992
Leukocyte reduction in blood component therapy
T A Lane, K C Anderson, L T Goodnough, et al.
Bone Marrow Transplantation
|
March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion
E Orsini, E P Alyea, R Schlossman, et al.
Blood
|
March 1, 1986
Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation
T Hercend, T Takvorian, A Nowill, et al.
Blood
|
March 1, 1985
Immunologic heterogeneity of diffuse large cell lymphoma
A S Freedman, A W Boyd, K C Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 5, 2000
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma
E Orsini, E P Alyea, A Chillemi, et al.
Transfusion Science
|
June 7, 1993
Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive
P T Pisciotto, K C Anderson, L T Goodnough, et al.
Blood
|
January 1, 1990
Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium
D C Roy, R Tantravahi, C Murray, et al.
Clinical and Experimental Immunology
|
July 28, 2005
Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients
B Maecker, M S von Bergwelt-Baildon, K S Anderson, et al.
Page
of 33